Xencor, Inc. (XNCR): Price and Financial Metrics

Xencor, Inc. (XNCR)

Today's Latest Price: $32.29 USD

0.10 (0.31%)

Updated Feb 28 1:39pm

Add XNCR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

XNCR Stock Summary

  • Of note is the ratio of Xencor Inc's sales and general administrative expense to its total operating expenses; only 7.3% of US stocks have a lower such ratio.
  • XNCR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 8.71% of US stocks.
  • As for revenue growth, note that XNCR's revenue has grown 312.09% over the past 12 months; that beats the revenue growth of 97.71% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Xencor Inc are PLX, CARA, LQDA, MRSN, and AGEN.
  • Visit XNCR's SEC page to see the company's official filings. To visit the company's web site, go to www.xencor.com.
XNCR Daily Price Range
XNCR 52-Week Price Range

XNCR Stock Price Chart More Charts

XNCR Price/Volume Stats

Current price $32.29 52-week high $46.33
Prev. close $32.19 52-week low $27.75
Day low $31.74 Volume 227,350
Day high $33.43 Avg. volume 303,060
50-day MA $35.77 Dividend yield N/A
200-day MA $36.89 Market Cap 1.84B

Xencor, Inc. (XNCR) Company Bio

Xencor Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases and cancer. The company was founded in 1997 and is based in Monrovia, California.

XNCR Latest News Stream

Event/Time News Detail
Loading, please wait...

XNCR Latest Social Stream

Loading social stream, please wait...

View Full XNCR Social Stream

XNCR Price Returns

1-mo -4.44%
3-mo -18.05%
6-mo -13.39%
1-year 6.43%
3-year 29.94%
5-year 106.99%
YTD -6.11%
2019 -4.89%
2018 64.96%
2017 -16.72%
2016 80.03%
2015 -8.85%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.703 seconds.